Showing results (1-10 of 605) with videos related to

Sort By:
Pageof 61
Biopharmaceutics & Drug Disposition|April 1, 1997
Metabolism of dextromethorphan in vitro: involvement of cytochromes P450 2D6 and 3A3/4, with a possible role of 2E1J Schmider, D J Greenblatt, S M Fogelman, et al.
The American Journal of Psychiatry|June 1, 1977
Clinical implications of benzodiazepine pharmacokineticsR I Shader, D J Greenblatt
The Journal of Clinical Psychiatry|November 1, 1983
Some current treatment options for symptoms of anxietyR I Shader, D J Greenblatt
Ciba Foundation Symposium|January 1, 1979
Benzodiazepines: some aspects of their clinical pharmacologyR I Shader, D J Greenblatt
Arzneimittel-Forschung|January 1, 1980
Effects of age and other drugs on benzodiazepine kineticsD J Greenblatt, R I Shader
American Journal of Hospital Pharmacy|January 1, 1975
Rational use of psychotropic drugs. IV. AntidepressantsD J Greenblatt, R I Shader
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 1, 1980
Pharmacokinetic aspects of anxiolytic drug therapyD J Greenblatt, R I Shader
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 8, 1999
O- and N-demethylation of venlafaxine in vitro by human liver microsomes and by microsomes from cDNA-transfected cells: effect of metabolic inhibitors and SSRI antidepressantsS M Fogelman, J Schmider, K Venkatakrishnan, et al.
Pharmacology|January 1, 1982
Liquid chromatographic determination of chlordiazepoxide and metabolites in plasmaM Divoll, D J Greenblatt, R I Shader
Pageof 61